<DOC>
	<DOCNO>NCT00898092</DOCNO>
	<brief_summary>RATIONALE : Collecting store sample tissue blood patient cancer study laboratory may help doctor learn change may occur DNA identify biomarkers related cancer . PURPOSE : This laboratory study look change DNA tissue sample collect patient acute myeloid leukemia .</brief_summary>
	<brief_title>Genetics Study Tissue Collected From Patients With Acute Myeloid Leukemia</brief_title>
	<detailed_description>OBJECTIVES : - Validate , large number patient karyotypically normal acute myeloid leukemia ( AML ) treat uniformly CALGB-19808 , preliminary result CALGB-9621 show BAALC ERG overexpression microarray gene-expression signature stratify patient prognostically . - Establish whether microRNAs differentially express subset patient AML normal cytogenetics , , , attempt identify signature stratify patient prognostically . - Explore relative contribution predict clinical outcome patient cytogenetically normal AML use genetic marker BAALC , ERG , EVI1 overexpression , MLL partial tandem duplication , FLT3 internal tandem duplication , NPM1 CEBPA mutation , microarray gene expression microRNA signature . OUTLINE : This multicenter , pilot study . Peripheral blood bone marrow sample analyze assess gene expression use polymerase chain reaction ( PCR ) reverse transcriptase-PCR assay microarray assay . Genes study include BAALC , ERB , EVI1 , MLL , FLT3 , NPM1 , CEBPA . PROJECTED ACCRUAL : A total 100 patient accrue study .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis acute myeloid leukemia Normal karyotype Bone marrow and/or peripheral blood sample patient treat CALGB19808 register CALGB9665 require No additional sample require</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>adult acute minimally differentiate myeloid leukemia ( M0 )</keyword>
	<keyword>adult acute myeloblastic leukemia without maturation ( M1 )</keyword>
	<keyword>adult acute myeloblastic leukemia maturation ( M2 )</keyword>
	<keyword>adult acute myelomonocytic leukemia ( M4 )</keyword>
	<keyword>adult acute monoblastic leukemia ( M5a )</keyword>
	<keyword>adult acute monocytic leukemia ( M5b )</keyword>
	<keyword>adult erythroleukemia ( M6a )</keyword>
	<keyword>adult pure erythroid leukemia ( M6b )</keyword>
	<keyword>adult acute megakaryoblastic leukemia ( M7 )</keyword>
	<keyword>adult acute eosinophilic leukemia</keyword>
	<keyword>adult acute basophilic leukemia</keyword>
	<keyword>untreated adult acute myeloid leukemia</keyword>
</DOC>